Results 41 to 50 of about 28,042 (215)

Interventional Mitral Valve Edge‐to‐Edge Repair in Patients Above 85 Years of Age

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral valve transcatheter‐edge‐to‐edge repair (M‐TEER) is routinely performed in patients with severe mitral regurgitation (MR) at high operative risk, frequently including elderly patients. Patients ≥ 85 years, however, are frequently excluded in clinical studies.
Florian Jürgens, Florian Schindhelm, Mohammed Abusharekh, Jürgen Kampf, Matthias Totzeck, Fadi Al‐Rashid, Peter Lüdike, Tienush Rassaf, Amir A. Mahabadi   +8 more
wiley   +1 more source

Integrating Pharmacists in HFrEF Outpatient Care to Improve Use of Guideline-Directed Medical Therapy [PDF]

, 2022
Background: Guideline directed medical therapy (GDMT) is the cornerstone of reducing mortality and morbidity in patients with heart failure with reduced ejection fraction (HFrEF); however, uniform prescribing remains low.
Wagner, Shauna, BSN, RN, Robertson, Roy, MD, Meisberger, Elizabeth, PharmD, Mirro, Michael, MD, FACC, FHRS, FAHA, Daley, Carly, PhD, Flanagan, Mindy, PhD, Howard, Kris, PharmD, Keltner, Emily, BS, MA, Singh, Lovekirat, MS, Toscos, Tammy, PhD   +9 more
core   +1 more source

Advanced heart failure with reduced ejection fraction at a young age: how long can we wait?

Cardiologia Hungarica
The pharmacotherapy and device therapy for heart failure with reduced ejection fraction (HFrEF) have advanced considerably. However, there are instances where even with optimal therapy following the guidelines’ recommendations, some patients may require ...
Arnold Péter Ráduly, Zsófia Pólik, Ágnes Balogh, László Balogh, Kriszti Medvés-Váczi, Ágnes Rácz, Bertalan Kracskó, Zoltán Csanádi, Attila Borbély   +8 more
doaj   +1 more source

Cardiovascular-Kidney-Metabolic Overlaps, Clinical Outcomes, and Medications Among Patients With Heart Failure: Results From the Chinese Cardiovascular Association Database-Heart Failure Center Registry. [PDF]

MedComm (2020)
In a nationwide heart failure cohort, cardiovascular–kidney–metabolic (CKM) multimorbidity was common in Chinese hospitalized heart failure (HF) patients and associated with poor prognosis. Higher CKM burden and combinations identified high‐risk patients.
Wang X, Li J, Li Y, Lei L, Wang W, Meng X, Xia C, Yang C, Zhang L, Liao Y, Li W, Dong Y, Li X, Zhou J, Yang J, Wang F.   +15 more
europepmc   +2 more sources

Outpatient treatment of decompensated heart failure: A systematic review and study level meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 761-769, April 2025.
Abstract Patients with acutely decompensated heart failure (ADHF) are usually admitted to hospital for management. There is growing interest in delivering intravenous (IV) diuretic therapy at home, in the community or at hospital day‐care units; the safety and effectiveness of outpatient‐based management (OPM) for ADHF has not been established.
Jameela Bahar, Amna Rahman, Grace W.Y. Wong, Rajiv Sankaranarayanan, Fozia Z. Ahmed, Rebecca Taylor, Ahmet Fuat, Iain Squire, John G.F. Cleland, Gregory Y.H. Lip, James H.P. Gamble, Sundas Masudi, Prince Josiah S. Joseph, Kenneth Y.K. Wong   +13 more
wiley   +1 more source

Use of Guideline-Recommended Heart Failure Drugs in High-, Middle-, and Low-Income Countries: A Systematic Review and Meta-Analysis

Global Heart
Optimal use of guideline-directed medical therapy (GDMT) can prevent hospitalization and mortality among patients with heart failure (HF). We aimed to assess the prevalence of GDMT use for HF across geographic regions and country-income levels.
Gautam Satheesh, Rupasvi Dhurjati, Laura Alston, Fisaha Tesfay, Rashmi Pant, Ehete Bahiru, Claudia Bambs, Anubha Agarwal, Sanne A. E. Peters, Abdul Salam, Isabelle Johansson   +10 more
doaj   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

VDD-ICD Implantation in a Patient with Dextrocardia and Corrected Transposition of the Great Arteries

Cardiologia Hungarica
We present the case of a 52-year-old female patient on optimal medical therapy (OMT) for heart failure with severely reduced ejection fraction. She was diagnosed with dextrocardia and congenital corrected transposition of the great arteries (ccTGA) by ...
Krisztián István Kássa, Zoltán Som, Attila Kardos, Csaba Földesi   +3 more
doaj   +1 more source

Integration of RNA-Seq and Machine Learning Identifies Hub Genes for Empagliflozin Benefitable Heart Failure with Reduced Ejection Fraction

Journal of Inflammation Research, 2023
Qiang Yang,1,* Jing Gao,2,* Tian-Yu Wang,1 Jun-Can Ding,1 Peng-Fei Hu3 1Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People’s Republic of China; 2Department of Cardiology, Sir Run Run ...
Yang Q, Gao J, Wang TY, Ding JC, Hu PF
doaj  

HFrEF pharmacological treatment: angiotensin receptor–neprilysin inhibitors

, 2018
The pathophysiological hallmarks of the syndrome of heart failure with reduced ejection fraction (HFrEF) are the activation of the renin–angiotensin–aldosterone system (RAAS) and the sympathetic nervous system.
Kieran F. Docherty, John J. V. McMurray
core   +1 more source